Nucleotide-based therapies are therapeutic approaches that use molecules containing nucleotides or their analogues to interact with biological processes. These therapies modify biological metabolic functions or the enzymes that use them. They have the potential to treat conditions once considered untreatable.

Nuvamid is using an Innovative Platform to develop proprietary nucleotides agents to adress orphan diseases challenges